Related Experiment Video
Updated: Aug 15, 2026
Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
Published on: August 4, 2023
Evaluation of hemorheological risk factor profile in plasmacytoma patients
S Ramakrishnan1, R Grebe, M Singh
1Institute of Physiology, Klinikum der RWTH, Aachen, Germany.
The hemorheological parameters, plasma viscosity, hematocrit, erythrocyte aggregation and deformability of blood samples obtained from plasmacytoma patients are measured by capillary viscometer, microcentrifuge, Myrenne aggregometer, and filtrometer, respectively. These parameters are significantly altered in patients compared to those of normal subjects. The plasma viscosity and erythrocyte aggregation are increased, whereas erythrocyte deformability and hematocrit are decreased. Based on these parameters the hemorheological risk factor profiles are developed and by their overall risk factors, the patients with low and high risk factors are identified.
The hemorheological parameters, plasma viscosity, hematocrit, erythrocyte aggregation and deformability of blood samples obtained from plasmacytoma patients are measured by capillary viscometer, microcentrifuge, Myrenne aggregometer, and filtrometer, respectively. These parameters are significantly altered in patients compared to those of normal subjects. The plasma viscosity and erythrocyte aggregation are increased, whereas erythrocyte deformability and hematocrit are decreased. Based on these parameters the hemorheological risk factor profiles are developed and by their overall risk factors, the patients with low and high risk factors are identified.
